Long-term data on safety and effectiveness of antiobesity drugs needed
...en unsuccessful. Currently, two antiobesity drugs orlistat and sibutramine - are licensed for long term use. Raj Padwal and Sumit Majumdar from the University of Alberta Hospital, Edmonton, AB, Canada assess these drugs as well as rimonabant the first of a new class of antiobesity drug known as the endocann...Nutrition expert evaluates new weight-loss medication
...version of the prescription weight-loss medication orlistat (marketed by GlaxoSmithKline as Xenical 120 mg) wa...ver, British Columbia. The study, which compared orlistat 60 mg plus diet to placebo plus diet in patients with a body mass index (BMI) of 25 to 28, demonstra...Medication orlistat appears helpful in improving weight management for obese adolescents
...olleagues examined the effectiveness and safety of orlistat for weight management in adolescents, in this 54-w...ee hundred fifty-seven patients received 120 mg of orlistat three times daily and 182 participants received placebo three times daily for one year. Both groups ...